Bilateral pheochromocytomas: clinical presentation and morbidity rate related to surgery technique and genetic status

Sofia Maria Lider Burciulescu,Monica Livia Gheorghiu,Andrei Muresan,Iuliana Gherlan,Patocs Attila,Corin Badiu
DOI: https://doi.org/10.1530/ec-23-0466
2024-02-08
Endocrine Connections
Abstract:Background: Pheochromocytomas (PHEOs) are rare catecholamine-secreting adrenal tumors. Approximately 60-90% of bilateral PHEOs are hereditary. We retrospectively analyzed the clinical characteristics of patients with bilateral PHEOs and the morbidity rate (malignancy, tumor recurrence and adrenal insufficiency rate) related to surgery technique and genetic status of the patients. Results: Fourteen patients (12.5%, 9 women, 5 men) had synchronous or metachronous bilateral PHEOs (out of 112 PHEO patients who underwent surgery between 1976-2021). Mean age at diagnosis was 35 ± 18.5 years (3 were children). Nine patients (64.2%) presented synchronous bilateral tumors, 5 (35.7%) contralateral metachronous tumors, 2-12 years after the first surgical intervention; 3 (21.4%) were metastatic. Median follow-up: 5 years (1-41), IQR 19 months. 78.5% had a germline mutation (8 RET gene with MEN2A syndrome, 3 VHL syndrome, 3 not tested). Post surgery recurrence was noted in 16.6% of patients (1 with MEN2A syndrome and metastatic PHEOs, 1 with VHL syndrome), with similar rates after total adrenalectomy or cortical-sparing adrenal surgery. Adrenal insufficiency was avoided in 40% after cortical-sparing surgery. Conclusion: Bilateral PHEOs are usually associated with genetic syndromes. The surgical technique for patients with hereditary bilateral PHEOs should be chosen based on a personalized approach, as they are at higher risk for developing new adrenal tumors requiring additional surgeries.
endocrinology & metabolism
What problem does this paper attempt to address?